Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON
  1. Startseite
  2. Aktien
  3. Vereinigtes Königreich
  4. London Stock Exchange
  5. Open Orphan plc
  6. News
  7. Andere Sprachen
    VENN   GB00B9275X97

OPEN ORPHAN PLC

(A1KAME)
  Bericht
verzögerte Kurse. Verzögert London Stock Exchange - 23.09. 17:35:20
22.5 GBX   -1.10%
20.09.Earnings Flash (ORPH.L) OPEN ORPHAN meldet H1-Umsatz von 21,9 Mio. GBP
MT
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über OPEN ORPHAN PLC
20.09.FTSE Tumbles on China, Inflation Worries
20.09.OPEN ORPHAN : hVIVO Signs $8 Million Influenza Human Challenge Study Deal
20.09.FTSE Seen Opening Lower, Tracking Weakness in Asia
20.09.UK Energy Retail Market Crisis Threatens Smaller Suppliers
20.09.Earnings Flash (ORPH.L) OPEN ORPHAN Reports H1 EPS GBX0.19
20.09.Earnings Flash (ORPH.L) OPEN ORPHAN Reports H1 Revenue GBP21.9M
20.09.Open Orphan plc Announces Unaudited Consolidated Earnings Results for the Half Year End..
20.09.Open Orphan plc Reports Earnings Results for the Half Year Ended June 30, 2021
24.08.OPEN ORPHAN : hVIVO Signs $11 Million Deal for Testing of Inhaled Human Rhinovirus Antivir..
09.08.OPEN ORPHAN : Study to Advance Antimalarial Drug, Vaccine Development
29.07.Open Orphan plc Announces Contract to Support Phase II River Blindness Drug Trial
15.07.Open Orphan Spin-Out Poolbeg Pharma on Track for £25 Million in Initial Public Offering
14.07.OPEN ORPHAN : Says UK Government to Expand COVID-19 Characterization Study; Shares Up 7%
14.07.Open Orphan plc Announces New Contract Win for Breda Office
12.07.AIM IMMUNOTECH : Announces Phase 2a Human Challenge Trial to Test its Drug Ampligen as an ..
09.07.AIM IMMUNOTECH : Announces Phase 2a Human Challenge Trial to Test its Drug Ampligen as an ..
17.06.CORRECTION : Open Orphan Tanks 14% Amid Plans to List Poolbeg Pharma on London's AIM Marke..
17.06.OPEN ORPHAN : Tanks 11% On Plans Poolbeg Pharma Unit IPO Plans On London's AIM Market
17.06.FTSE Edges Lower as Fed Signals Earlier Rate Rise; Whitbread Gains
17.06.FTSE Seen Opening Lower After Fed Signaled Earlier Rate Rise
17.06.Earnings Flash (ORPH.L) OPEN ORPHAN Posts FY20 Revenue GBP22M
17.06.Earnings Flash (ORPH.L) OPEN ORPHAN Posts FY20 Loss GBX-1.80
17.06.Open Orphan plc Reports Consolidated Earnings Results for the Year Ended 31 December 20..
10.05.OPEN ORPHAN : Confirms Contract with Imperial College London to Manufacture COVID-19 Chall..
10.05.OPEN ORPHAN : Secures $4.2 Million Contract To Study COVID-19 Variants
13.04.Open Orphan Announces Potential Demerger of Certain Non-Core Assets
13.04.Open Orphan plc agreed to Spin-Off A Portfolio Of Intellectual Property And Development..
26.03.OPEN ORPHAN : hVIVO Wins Contract to Conduct Study for US Biopharmaceutical Company
25.03.OPEN ORPHAN : Says First Volunteers in COVID-19 Characterization Study Clear Quarantine Ph..
25.03.Open Orphan plc Announce Covid-19 Human Challenge Programme Update
09.03.OXFORD BIOMEDICA : Open Orphan Unit Signs Contract With Oxford BioTherapeutics To Study Br..
17.02.Open Orphan plc Receives Approval from Specially Convened Research Ethics Committee
17.02.UPDATE : Open Orphan Subsidiary To Conduct UK's First COVID-19 Human Challenge Study; Shar..
17.02.Open Orphan plc Announces Ethics Approval for Covid-19 Human Challenge Study
03.02.OPEN ORPHAN : hVIVO Opens New Quarantine Clinic In East London
03.02.Open Orphan plc Opens New Quarantine Clinic in East London
01.02.Open Orphan Plc's Subsidiary Venn Life Sciences Announces Contract Extension with Carna..
20.01.OPEN ORPHAN : Opens Two New Volunteer Centers In England
20.01.Open Orphan plc Announces Expansion of Volunteer Recruitment Centres for Human Challeng..
11.01.OPEN ORPHAN : Clinical Trial for Codagenix's COVID-19 Vaccine Candidate Doses First Volunt..
06.01.OPEN ORPHAN : Extends Consultancy Contract With Pharmaceutical Client Until December-End
06.01.Open Orphan plc Announces Contract Renewal with Top-3 Pharmaceutical Client Extending I..
2020OPEN ORPHAN : PrEP Biopharm Unit Completes Toxicology Study For Respiratory Prophylactic A..
2020OPEN ORPHAN : Renews Contract To Extend Consultancy Services For Pharmaceutical Client
2020Open Orphan plc Announces Contract Renewal Extending Its Consultancy Services with A Ma..
2020OPEN ORPHAN : Britain's Medicines Regulator OKs Open Orphan's Clinical Trial for Codagenix..
2020OPEN ORPHAN : Unit Wins Two Contracts In France, Netherlands From European Pharmaceutical ..
2020Open Orphan plc Announces Board Changes, Effective on December 31, 2020
2020OPEN ORPHAN : Unit to Lead Consortium Developing Guidelines on Human Challenge Studies
2020OPEN ORPHAN : Lands $3.3 Million Contract for Influenza Human Challenge Study
2020Open Orphan plc Announces the Signs of A £2.5 Million Contract by hVIVO
2020Open Orphan plc Announces New 2-Year Contract with A Tier 1 German Pharmaceutical Compa..
2020Open Orphan plc Announces Unaudited Consolidated Earnings Results for the Half Year End..
2020Open Orphan plc Announces £4.3 Million Contract to Conduct Human Viral Challenge Study
2020Open Orphan plc Wins New Contract with Top 3 Pharma Company
2020Open Orphan Plc's Venn Life Sciences Wins New Contract with Carna Bioscience
2020Open Orphan plc Receives Contract for COVID-19 Vaccine Trial
2020Open Orphan plc Signs Additional Laboratory Services Contracts
2020Open Orphan plc Reports Consolidated Earnings Results for the Year Ended 31 December 20..
2020Open Orphan plc Announces Positive Phase I Results Published in the Lancet
2020Open Orphan plc Signs New Contract
2020Open Orphan plc Announces the Launch of hVIVO COVID Clear Test
2020Open Orphan plc Announces Directorate Changes; Announce the Signing of a New Contract
2020OPEN ORPHAN : Publication of positive results in journal ● ●
2020OPEN ORPHAN : Publication of positive results in journal
2020Open Orphan plc Announces Publication of Positive Results in Journal
2020OPEN ORPHAN : Holding(s) in Company ●
2020OPEN ORPHAN : Publication of Positive Results in Journal ●
2020Open Orphan plc Announces Publication of Positive Results in Journal
2020OPEN ORPHAN : Completion of Compulsory Acquisition of Shares ● ●
2020OPEN ORPHAN : Completion of Compulsory Acquisition of Shares
2020OPEN ORPHAN : Coronavirus Challenge Study Model
2020OPEN ORPHAN : New Contract ● ●
2020OPEN ORPHAN : New Contract
2020Open Orphan plc Signs New Contract with a European Biotech Company
1  2Weiter
Anstehende Termine für OPEN ORPHAN PLC